Mirum CEO Christopher Peetz sells 30,000 shares for $2.95 million

Reuters2026/09/03 22:53

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Mirum Pharmaceuticals CEO Christopher Peetz sold 30,000 common shares on Sep. 1, 2026 at weighted average prices of USD 98.08 and USD 98.91.
Disposition followed the exercise of 30,000 employee stock options at USD 2.94 per share.
Direct holdings ended at 194,440 shares.
Indirect holdings via the Peetz Family Trust totaled 187,500 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001614740-26-000013), on September 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Mirum CEO Christopher Peetz sells 30,000 shares for $2.95 million

You may also like

Crypto prices